Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$7.2 - $9.47 $2,124 - $2,793
295 Added 1.34%
22,246 $167,000
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $22,195 - $30,187
2,655 Added 13.76%
21,951 $194,000
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $57,796 - $68,919
7,270 Added 60.45%
19,296 $175,000
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $82,498 - $143,710
12,026 New
12,026 $0

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.